MedDataX Logo

Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4

NCT ID: NCT01215045

Last Updated: 2010-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-06-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Determine the clinical visual outcomes following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) and to demonstrate what percentage of the subjects obtain spectacle freedom.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ReSTOR +4

AcrySof ReSTOR Aspheric +4

AcrySof ReSTOR Aspheric +4

Intervention Type DEVICE

Implantation with the AcrySof ReSTOR Aspheric +4 Multifocal Intraocular Lens (IOL)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AcrySof ReSTOR Aspheric +4

Implantation with the AcrySof ReSTOR Aspheric +4 Multifocal Intraocular Lens (IOL)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with cataracts

Exclusion Criteria

* Preexisting conditions confounding results; \> 1 Diopter preoperative astigmatism
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alcon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M07-004

Identifier Type: -

Identifier Source: org_study_id